Help me spreading the word @dufour_jf about HCC Day 2026 in Bern and online, on Feb. 26th 2026 https://t.co/xWpwslWhEk register here- https://t.co/VTetP1Q16A
Peter Galle presents ABC-HCC, academic study of atezolizumab-bevacizumab vs TACE for intermediate stage #HCC.
Improved time to failure of treatment strategy with #systemic therapy.
Positive study, potential novel approach for #intermediate HCC
#ESMO25#ESMOAmbassadors@myESMO
One of the reasons why it is so difficult to maintain weight loss is because adipose issue retains an epigenetic memory of obesity after weight loss.
https://t.co/BvNcuLdhYB
1) Our manuscript entitled « Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments” was recently released in Gut
https://t.co/ltZjV3uUQC
@campani_claudia @CRCordeliers @SRebouissou@GUTJournal_BMJ@TZ_Hirsch@SImbeaud
Read the new @BritSocGastro#GUTGuideline by Suddle et al entitled
"British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults" via https://t.co/a8IovZ6ez0
@DinaTiniakos#HCC
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes | Gut https://t.co/ltpX0IWtev
Barcelona is walking the walk and getting in their steps today! A great way to experience Barcelona following a fantastic NIT Summit and SLD Think-Tank the last 2 days. Congratulations to @JVLazarus Lazarus and @schattenbergJ, the amazing faculty and all the participants that made it so interactive and collaborative!
@AASLDtweets@EASLnews #sldthinktank @CASLupdates #livertwitter #liverx
#BREAKING It is a big day for the Liver Community! Madrigal is proud to announce the first and only @US_FDA-approved therapy in NASH/MASH. Learn more here: https://t.co/uk0y7XTgG3 #FDAApproval#NASH
A pleasure to give the annual prize of the Swiss Foundation against Liver Cancer to Dr Melloul and Dr Martin for their work on HCC burden and liver resection. @EmmanuelMelloul @InfoCancerFoie @CHUVLausanne
Free Debrief on HCC with @SaborowskiAnna, K. Kelley, R. Finn, R. Lencioni, P. Galle on 29th of February Program&registration https://t.co/Qh1M2rzAa4 @InfoCancerFoie
Obese diabetes patients with [non-alcoholic] fatty liver disease and related chronic liver disease ask me if they have to avoid "rice" from their diet.
We are a predominantly rice consuming population, which means, there will be great inertia about getting rice out of the daily diet.
Good news is, there is absolutely no need to avoid rice from diet in people with diabetes, obesity and chronic liver disease.
Rice contains about 80% starch and is generally considered a high glycaemic index food. GIycemic index is a measure of glucose uptake upon digestion (or postprandial glucose), resulting in a sudden spike in blood glucose content.
There is simple hack to enjoy rice with a reduced glucose spike and stress on glycemic status.
Cook rice. But do not eat it immediately.
Refrigerate it at a minimum of 4°C.
That is, let it cool for 24 hours.
Reheat and consume it the next day.
During the cooling of cooked rice, the structure of the starch in rice takes on a crystalline form that can resist enzymatic digestion in the small intestine for up to three hours - that is cooled rice gains "resistant starch" which is digested more slowly and with lower glucose spikes.
So enjoy your daily portion of rice within the calculated calorie content and do not completely remove it from diet.
Sources:
[1] https://t.co/LNWBAvT6s5
[2] https://t.co/PIgZxnHwjd
Join us on the 30. November 2023 for our Symposium "2023 a pivotal year for NASH" you find the agenda here: https://t.co/xBG7mTAD39 #nash#nafld#LiverTwitter#LiverX
The registration is open for the upcoming virtual symposium „2023 - a pivotal year for NASH“ please join us for talks and discussions with international experts!
#NASH#NAFLD#LiverTwitter
https://t.co/7iO4G4vv1l
#GUTAbstract by Zhang & @TerryYip12 on
"Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation..." via https://t.co/3sjC5jnjEH
Paper: https://t.co/AeVUR2BclB
@wonglaihung@LeeLingLim1@VWSWong